Business

ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change

Feb 20, 2026 - 11:00
 0
ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change
Read More

Related Posts

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  7

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025  3

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  7

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  1

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025  0